Next year key milestones outlook:
In 2017 we established PainChekTM as the world’s first pain assessment app using artificial intelligence and with regulatory clearance. The market has responded very positively and we now ideally positioned to build on the solid foundations created over the past year.
Key objectives for calendar year 2018 year are:
- - successful commercialization of the enterprise version of PainChekTM for Dementia in Australia and selected European markets;
- - obtaining FDA regulatory clearance of PainChekTM for Dementia in the USA;
- - developing and launching a consumer version of PainChekTM for Dementia;
I see your point...
- Forums
- ASX - By Stock
- PCK
- EPAT General Discussion
EPAT General Discussion, page-767
-
-
- There are more pages in this discussion • 292 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
|
|||||
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $47.43M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.8¢ | $19.97K | 697.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1419145 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.9¢ | 206943 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1419145 | 0.028 |
8 | 1053639 | 0.027 |
3 | 185422 | 0.026 |
4 | 3079000 | 0.025 |
1 | 25000 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.029 | 206943 | 1 |
0.030 | 1224635 | 3 |
0.031 | 55555 | 1 |
0.032 | 24900 | 1 |
0.033 | 410208 | 3 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |